These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11432379)

  • 1. [Cosmetics--European Parliament demands marketing prohibition].
    Ruhdel I
    ALTEX; 2001; 18(2):149-51. PubMed ID: 11432379
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cosmetics: EU Commission subjects itself to the WTO and the cosmetic industry].
    Ruhdel II
    ALTEX; 2000; 17(2):103-4. PubMed ID: 11085864
    [No Abstract]   [Full Text] [Related]  

  • 3. [EU: 2003/15 guidelines for changing cosmetic guidelines dismissed].
    ALTEX; 2003; 20(2):92. PubMed ID: 12848133
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
    Lodén M; Ungerth L; Serup J
    Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REACH: impact on the US cosmetics industry?
    Pouillot A; Polla B; Polla A
    J Cosmet Dermatol; 2009 Mar; 8(1):3-7. PubMed ID: 19250158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good laboratory practice in the European Community. Role of the commission and the member states: external aspects.
    Berend K
    Ann Ist Super Sanita; 2002; 38(1):9-13. PubMed ID: 12122900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Headlines of safety assessment of cosmetics in Europe and future perspectives.
    Rogiers V; Pauwels M
    Curr Probl Dermatol; 2008; 36():166-82. PubMed ID: 18806458
    [No Abstract]   [Full Text] [Related]  

  • 8. Quality control in the European Union.
    Van Ackern K; Runck M; Striebel JP
    Acta Anaesthesiol Scand Suppl; 1996; 109():10-3. PubMed ID: 8901927
    [No Abstract]   [Full Text] [Related]  

  • 9. [EU-Cosmetics: timetables for the replacement of animal experiments].
    Ruhdel IW
    ALTEX; 2005; 22(2):117-9. PubMed ID: 15953967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expected change of direction in Polish law regarding cosmetics].
    Karłowski K; Smietanka B; Biernat U; Burzyńska I; Pawłowska K
    Rocz Panstw Zakl Hig; 2004; 55(1):21-5. PubMed ID: 15307612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomaterials and regulation of cosmetics.
    Bowman DM; van Calster G; Friedrichs S
    Nat Nanotechnol; 2010 Feb; 5(2):92. PubMed ID: 20130584
    [No Abstract]   [Full Text] [Related]  

  • 12. [Supervision of cosmetic products].
    Urbanek-Karłowska B; Smietanka B; Pawłowska K; Biernat U; Burzyńska I
    Rocz Panstw Zakl Hig; 2001; 52(3):257-65. PubMed ID: 11771119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality and safety guidelines of postanaesthesia care: Working Party on Post Anaesthesia Care (approved by the European Board and Section of Anaesthesiology, Union Européenne des Médecins Spécialistes).
    Vimlati L; Gilsanz F; Goldik Z
    Eur J Anaesthesiol; 2009 Sep; 26(9):715-21. PubMed ID: 19390443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the new quality management system standards on the CE-marking process.
    Donawa M
    Med Device Technol; 2001; 12(1):34-9. PubMed ID: 11317864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of COLIPA guidelines for assessment of skin compatibility on the development of cosmetic products.
    Meloni M; Berardesca E
    Am J Clin Dermatol; 2001; 2(2):65-8. PubMed ID: 11705305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety assessment of cosmetics in Europe. Preface.
    Rogiers V; Pauwels M
    Curr Probl Dermatol; 2008; 36():XVII-XX. PubMed ID: 19177695
    [No Abstract]   [Full Text] [Related]  

  • 17. International Conference on Harmonisation; guidance on Q9 Quality Risk Management; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jun; 71(106):32105-6. PubMed ID: 16795933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent developments on the European ban on animal experiments for cosmetics].
    Ruhdel IW
    ALTEX; 2001; 18(1):13-6. PubMed ID: 11248844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strengthening of EU policies. Forum of Parliamentarians.
    Sandbaek U
    Integration; 1999; (60):13-4. PubMed ID: 12322182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Not long to go: the end of the transition period approaches.
    Cutler IR
    Med Device Technol; 1997 Nov; 8(9):28-30. PubMed ID: 10174627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.